KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EBT (2016 - 2025)

Historic EBT for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $6.7 billion.

  • Merck's EBT rose 6491.44% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 billion, marking a year-over-year increase of 5901.6%. This contributed to the annual value of $19.9 billion for FY2024, which is 95537.32% up from last year.
  • Per Merck's latest filing, its EBT stood at $6.7 billion for Q3 2025, which was up 6491.44% from $5.0 billion recorded in Q2 2025.
  • Merck's 5-year EBT high stood at $6.7 billion for Q3 2025, and its period low was -$5.3 billion during Q2 2023.
  • Moreover, its 5-year median value for EBT was $4.2 billion (2024), whereas its average is $3.7 billion.
  • In the last 5 years, Merck's EBT plummeted by 21889.9% in 2023 and then soared by 30381.23% in 2024.
  • Over the past 5 years, Merck's EBT (Quarter) stood at $3.9 billion in 2021, then dropped by 10.13% to $3.5 billion in 2022, then plummeted by 158.24% to -$2.0 billion in 2023, then skyrocketed by 303.81% to $4.2 billion in 2024, then soared by 61.75% to $6.7 billion in 2025.
  • Its EBT was $6.7 billion in Q3 2025, compared to $5.0 billion in Q2 2025 and $5.9 billion in Q1 2025.